S. Miyamoto

发表

New approach to cancer therapy: heparin binding-epidermal growth factor-like growth factor as a novel targeting molecule.

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2007, Anticancer research.

Heparin‐binding epidermal growth factor‐like growth factor as a novel targeting molecule for cancer therapy

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2006, Cancer science.

7 Role of Immunohistochemical Expression of Ki-67 in Ovarian Carcinoma

S. Miyamoto, Y. Oda, M. Tsuneyoshi, 2006 .

Selective PGE2 Suppression Inhibits Colon Carcinogenesis and Modifies Local Mucosal Immunity

Takuji Tanaka, S. Miyamoto, D. Rosenberg, 2011, Cancer Prevention Research.

Ultrasound-based logistic regression model LR2 versus magnetic resonance imaging for discriminating between benign and malignant adnexal masses: a prospective study

Y. Ohgiya, S. Miyamoto, M. Kushima, 2018, International Journal of Clinical Oncology.

Effects of NSAIDs on the risk factors of colorectal cancer: a mini review

S. Miyamoto, K. Wakabayashi, Y. Totsuka, 2016, Genes and Environment.

Impact of Acetazolamide, a Carbonic Anhydrase Inhibitor, on the Development of Intestinal Polyps in Min Mice

S. Miyamoto, M. Mutoh, S. Tanuma, 2017, International journal of molecular sciences.

Suppression of colon carcinogenesis by targeting Notch signaling.

S. Miyamoto, D. Rosenberg, M. Nakanishi, 2013, Carcinogenesis.

Expression patterns of emmprin and monocarboxylate transporter-1 in ovarian epithelial tumors

S. Miyamoto, T. Kawarabayashi, K. Nabeshima, 2012, Virchows Archiv.

Proteolysis of EphA2 Converts It from a Tumor Suppressor to an Oncoprotein.

Alissa M. Weaver, S. Miyamoto, K. Nabeshima, 2015, Cancer research.

High mortality and poor treatment efficacy of immune checkpoint inhibitors in patients with severe grade checkpoint inhibitor pneumonitis in non‐small cell lung cancer

S. Miyamoto, H. Kunitoh, N. Awano, 2019, Thoracic cancer.

Treatment effect and safety profile of salvage chemotherapy following immune checkpoint inhibitors in lung cancer

S. Miyamoto, H. Kunitoh, N. Awano, 2019, Lung cancer management.

[Multidisciplinary approach to management of patients with brain metastases].

S. Miyamoto, Y. Tabei, I. Suzuki, 2013, Gan to kagaku ryoho. Cancer & chemotherapy.

Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer.

S. Miyamoto, E. Mekada, H. Nakano, 2003, Cancer letters.

Preventive effects of chrysin on the development of azoxymethane-induced colonic aberrant crypt foci in rats.

Takuji Tanaka, S. Miyamoto, A. Murakami, 2006, Oncology reports.

CDKN 2 A FISH in Differentiation of Diffuse Malignant Peritoneal Mesothelioma From Mesothelial Hyperplasia and Epithelial Ovarian Cancer

S. Miyamoto, K. Nabeshima, M. Hamasaki, 2015 .

p16/CDKN2A FISH in Differentiation of Diffuse Malignant Peritoneal Mesothelioma From Mesothelial Hyperplasia and Epithelial Ovarian Cancer.

S. Miyamoto, K. Nabeshima, M. Hamasaki, 2015, American journal of clinical pathology.

Association between RCAS1 expression and microenvironmental immune cell death in uterine cervical cancer.

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2005, Gynecologic oncology.

Apoptosis as a possible candidate mechanism for removal of tamoxifen-related endometrial cells with KRAS mutations.

S. Miyamoto, Fusanori Yotsumoto, T. Yoshizato, 2010, Anticancer research.

Monitoring of Endometrial K-ras Mutation in Tamoxifen-Treated Patients With Breast Cancer

S. Miyamoto, S. Horiuchi, T. Yoshizato, 2009, International Journal of Gynecologic Cancer.

Lack of Enhancing Effect of Lauric Acid on the Development of Aberrant Crypt Foci in Male ICR Mice Treated with Azoxymethane and Dextran Sodium Sulfate

Takuji Tanaka, S. Miyamoto, A. Murakami, 2007 .

Dietary flavonoids as cancer-preventive and therapeutic biofactors.

S. Miyamoto, H. Ashida, A. Murakami, 2011 .

Peri-operative complications of Total laparoscopic hysterectomy for benign gynecological diseases in Fukuoka university

S. Miyamoto, Fusanori Yotsumoto, Y. Kanamori, 2021, JAPANESE JOURNAL OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY.

Platinum hypersensitivity and desensitization.

S. Miyamoto, K. Ando, Rika Okada, 2015, Japanese journal of clinical oncology.

Soluble heparin-binding EGF-like growth factor (HB-EGF) detected by newly developed immuno-PCR method is a clear-cut serological biomarker for ovarian cancer.

S. Miyamoto, Fusanori Yotsumoto, E. Mekada, 2012, American journal of translational research.

Analysis of vaginal and endometrial microbiota communities in infertile women with a history of repeated implantation failure

Y. Nagai, S. Miyamoto, A. Itakura, 2020, Reproductive medicine and biology.

Age-related changes in thickness of anterior lower uterine segment in normal singleton pregnancy during 20–35 weeks’ gestation

S. Miyamoto, Fusanori Yotsumoto, T. Yoshizato, 2016, Journal of Medical Ultrasonics.

A partial supernumerary umbilical vein: a case report

S. Miyamoto, Fusanori Yotsumoto, M. Hamasaki, 2019, Journal of Medical Case Reports.

Invasive potency related to RCAS1 expression in uterine cervical cancer.

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2005, Gynecologic oncology.

The Significant Antitumor Activity of Nivolumab in Lung Adenocarcinoma with Choriocarcinomatous Features

S. Miyamoto, Y. Terada, S. Ikushima, 2018, Internal medicine.

A specific inducible nitric oxide inhibitor, ONO‐1714 attenuates inflammation‐related large bowel carcinogenesis in male ApcMin/+ mice

Takuji Tanaka, S. Miyamoto, K. Wakabayashi, 2007 .

Feasibility study of first-line chemotherapy using Pemetrexed and Bevacizumab for advanced or recurrent nonsquamous non-small cell lung cancer in elderly patients: TORG1015

Masahiro Yoshida, S. Miyamoto, S. Ikeda, 2016, BMC Cancer.

The Level of RCAS1 Expression Is Inversely Correlated With the Number of Vimentin-Positive Stromal Cells in Epithelial Ovarian Cancer

S. Miyamoto, N. Wake, K. Sonoda, 2009, International Journal of Gynecologic Cancer.

Receptor-binding cancer antigen expressed on SiSo cells induces apoptosis via ectodomain shedding.

S. Miyamoto, N. Wake, M. Nakashima, 2010, Experimental cell research.

Separation efficiency of a microfluidic sperm sorter to minimize sperm DNA damage.

S. Miyamoto, Fusanori Yotsumoto, H. Itoh, 2016, Fertility and sterility.

Clinical significance of RCAS1 as a biomarker of uterine cancer.

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2006, Gynecologic oncology.

Preventive Effects of Heat-Killed Enterococcus faecalis Strain EC-12 on Mouse Intestinal Tumor Development

S. Miyamoto, M. Mutoh, Masami Komiya, 2017, International journal of molecular sciences.

Sodium salicylate and 5-aminosalicylic acid synergistically inhibit the growth of human colon cancer cells and mouse intestinal polyp-derived cells

M. Horinaka, S. Miyamoto, Takumi Narita, 2021, Journal of clinical biochemistry and nutrition.

A prostaglandin E2 receptor subtype EP1-selective antagonist, ONO-8711, suppresses 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis.

Takuji Tanaka, S. Miyamoto, T. Shibata, 2006, Carcinogenesis.

Curcumin combined with turmerones, essential oil components of turmeric, abolishes inflammation-associated mouse colon carcinogenesis.

Takuji Tanaka, S. Miyamoto, A. Murakami, 2013, BioFactors.

Suppressive effects of the NADPH oxidase inhibitor apocynin on intestinal tumorigenesis in obese KK‐A y and Apc mutant Min mice

S. Miyamoto, Y. Totsuka, Mami Takahashi, 2015, Cancer science.

Differential proteomics identifies PDIA3 as a novel chemoprevention target in human colon cancer cells

S. Miyamoto, D. Drew, D. Rosenberg, 2014, Molecular carcinogenesis.

HB-EGF Is a Promising Therapeutic Target for Lung Cancer with Secondary Mutation of EGFRT790M.

S. Miyamoto, Fusanori Yotsumoto, S. Manabe, 2017, Anticancer research.

HB-EGF inhibition in combination with various anticancer agents enhances its antitumor effects in gastric cancer.

S. Miyamoto, Fusanori Yotsumoto, S. Horiuchi, 2010, Anticancer research.

A Novel Prodrug of 4′-Geranyloxy-Ferulic Acid Suppresses Colitis-Related Colon Carcinogenesis in Mice

Takuji Tanaka, S. Miyamoto, S. Genovese, 2008, Nutrition and cancer.

Assessment of HB-EGF levels in peritoneal fluid and serum of ovarian cancer patients using ELISA.

S. Miyamoto, Fusanori Yotsumoto, S. Horiuchi, 2011, Anticancer research.

Four-year experience with prenatal diagnosis of congenital heart defects at a single referral center in Japan with focus on inaccurately diagnosed cases

S. Miyamoto, T. Yoshizato, S. Hirose, 2012, Journal of medical ultrasonics.

Medical costs of Japanese lung cancer patients during end-of-life care.

S. Miyamoto, H. Kunitoh, A. Igarashi, 2021, Japanese journal of clinical oncology.

Anticarcinogenic Effects of Dried Citrus Peel in Colon Carcinogenesis Due to Inhibition of Oxidative Stress

S. Miyamoto, K. Wakabayashi, Satoru Takahashi, 2017, Nutrition and cancer.

Clinical significance of RCAS1 as a biomarker of ovarian cancer.

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2007, Oncology Report.

Target for Ovarian Cancer Therapy Heparin-Binding EGF-Like Growth Factor Is a Promising

M. Kai, S. Miyamoto, H. Yagi, 2004 .

The role of p53 inactivation in human cervical cell carcinoma development.

S. Miyamoto, N. Wake, H. Kato, 1995, British Journal of Cancer.

Chemopreventive effects of a low-side-effect antibiotic drug, erythromycin, on mouse intestinal tumors

S. Miyamoto, K. Wakabayashi, Susumu Tomono, 2017, Journal of clinical biochemistry and nutrition.

Clinical Efficacy of Aprepitant in Patients with Gynecological Cancer after Chemotherapy Using Paclitaxel and Carboplatin.

S. Miyamoto, Yoko Takahashi, H. Kondo, 2015, Anticancer research.

Theracurmin inhibits intestinal polyp development in Apc‐mutant mice by inhibiting inflammation‐related factors

S. Miyamoto, T. Takayama, K. Tashiro, 2020, Cancer science.

Nivolumab and stereotactic radiation therapy for the treatment of patients with Stage IV non-small-cell lung cancer

S. Miyamoto, H. Kunitoh, Y. Terada, 2018, Japanese journal of clinical oncology.

Anticancer drugs during pregnancy.

S. Miyamoto, M. Yamada, K. Andoh, 2016, Japanese journal of clinical oncology.

A tobacco-specific carcinogen, NNK, enhances AOM/DSS-induced colon carcinogenesis in male A/J mice.

Takuji Tanaka, S. Miyamoto, H. Nakagama, 2008, In vivo.

A marine bio-functional lipid, fucoxanthinol, attenuates human colorectal cancer stem-like cell tumorigenicity and sphere formation

Takuji Tanaka, S. Miyamoto, K. Miyashita, 2017, Journal of clinical biochemistry and nutrition.

Safety and efficacy of thromboprophylaxis using enoxaparin sodium after cesarean section: A multi-center study in Japan.

S. Miyamoto, T. Yoshizato, S. Satoh, 2015, Taiwanese journal of obstetrics & gynecology.

Dietary flavonoids as cancer-preventive and therapeutic biofactors.

S. Miyamoto, H. Ashida, A. Murakami, 2011, Frontiers in bioscience.

Drug review: Pazopanib

S. Miyamoto, A. Ishikawa, Shigenori Kakutani, 2018, Japanese journal of clinical oncology.

Zerumbone, a tropical ginger sesquiterpene, inhibits colon and lung carcinogenesis in mice

Takuji Tanaka, S. Miyamoto, A. Murakami, 2009, International journal of cancer.

The Safety of Pegylated Liposomal Doxorubicin Plus Irinotecan in Recurrent Ovarian Cancer Patients: A Phase I Trial.

S. Miyamoto, H. Kondo, S. Nam, 2015, Anticancer research.

Association between RCAS1 expression and clinical outcome in uterine endometrial cancer

S. Miyamoto, T. Kaku, T. Hirakawa, 2003, British Journal of Cancer.

Surveillance of radical hysterectomy for early-stage cervical cancer in the early experienced period of minimally invasive surgery in Japan

S. Miyamoto, K. Ushijima, T. Enomoto, 2021, International Journal of Clinical Oncology.

Chromosome alterations contribute to neoplastic progression of transformed rat embryonal fibroblasts.

S. Miyamoto, N. Wake, K. Fujinaga, 1992, Cancer genetics and cytogenetics.

Long-term survival following metachronous intratumoral hemorrhage in an HIV-infected patient with lung cancer

Y. Hosomi, M. Shibuya, S. Miyamoto, 2010, International Journal of Clinical Oncology.

Increased actin cable organization after single chromosome introduction: Association with suppression of in vitro cell growth rather than tumorigenic suppression

M. Oshimura, J. Barrett, S. Miyamoto, 1994, Molecular carcinogenesis.

Targeting Bcl-2 family proteins in adult T-cell leukemia/lymphoma: in vitro and in vivo effects of the novel Bcl-2 family inhibitor ABT-737.

S. Miyamoto, Fusanori Yotsumoto, C. Ishikawa, 2012, Cancer letters.

Chemopreventive effects of low-dose aspirin on colorectal carcinogenesis

S. Miyamoto, K. Wakabayashi, Toshiyuki Sakai, 2016 .

Anticoagulant Therapy in a Pregnant Woman with May-Thurner Syndrome.

S. Miyamoto, S. Miura, K. Saku, 2016, Internal medicine.

Adult Granulosa Cell Tumor of the Ovary with Endometrioid Adenocarcinoma of the Uterus

T. Okai, S. Miyamoto, H. Akita, 2008 .

Prenatal Diagnosis of High Grade Atrioventricular Block with Polymorphic Ventricular Premature Contractions due to Congenital Long QT Syndrome Using Doppler Flow Recording

S. Miyamoto, T. Yoshizato, S. Hirose, 2013 .

Transcriptional repression of smooth‐muscle α‐actin gene associated with human papillomavirus type 16 E7 expression

J. Barrett, S. Miyamoto, N. Wake, 1995, Molecular carcinogenesis.

Antitumour Effects of Intravenous Administration of BK-UM, a Novel Inhibitor of HB-EGF, in Ovarian Cancer Therapy.

S. Miyamoto, Fusanori Yotsumoto, S. Manabe, 2017, Anticancer research.

Validity of HB-EGF as Target for Human Neuroblastoma Therapy.

S. Miyamoto, Fusanori Yotsumoto, M. Kuroki, 2015, Anticancer research.

Involvement of anticentromere antibody in interference with oocyte meiosis and embryo cleavage.

S. Miyamoto, T. Yoshizato, H. Tsujioka, 2011, Fertility and sterility.

Amphiregulin regulates the production of human chorionic gonadotropin in trophoblasts.

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2009, Life sciences.

9trans,11trans Conjugated Linoleic Acid Inhibits the Development of Azoxymethane-Induced Colonic Aberrant Crypt Foci in Rats

Takuji Tanaka, S. Miyamoto, K. Miyashita, 2007, Nutrition and cancer.

Serum Heparin-binding Epidermal Growth Factor-like Growth Factor (HB-EGF) as a Biomarker for Primary Ovarian Cancer.

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2017, Anticancer research.

Amphiregulin is much more abundantly expressed than transforming growth factor-alpha and epidermal growth factor in human follicular fluid obtained from patients undergoing in vitro fertilization-embryo transfer.

S. Miyamoto, Fusanori Yotsumoto, T. Kawarabayashi, 2009, Fertility and sterility.

Takotsubo (ampulla-shaped) cardiomyopathy associated with microscopic polyangiitis.

S. Miyamoto, H. Matsuno, N. Kobayakawa, 2005, Internal medicine.

Fibrin Adhesive Spray Occlusion using a Laparoscope for Intractable Chylous Ascites: Case Report

S. Miyamoto, A. Sekizawa, T. Ishikawa, 2014 .

A lipophilic statin, pitavastatin inhibits inflammation-associated mouse colon carcinogenesis

Takuji Tanaka, S. Miyamoto, H. Kohno, 2007 .

Percutaneous cardiopulmonary support for pulmonary thromboembolism caused by large uterine leiomyomata.

S. Miyamoto, T. Yoshizato, H. Ishikura, 2012, Taiwanese journal of obstetrics & gynecology.

Adipose tissue-derived regenerative cells improve implantation of fertilized eggs in thin endometrium.

S. Miyamoto, Fusanori Yotsumoto, S. Sobajima, 2020, Regenerative medicine.

Ursodeoxycholic Acid versus Sulfasalazine in Colitis-Related Colon Carcinogenesis in Mice

Takuji Tanaka, S. Miyamoto, K. Wakabayashi, 2007, Clinical Cancer Research.

Warburg effect regulated by amphiregulin in the development of colorectal cancer

S. Miyamoto, Fusanori Yotsumoto, M. Kuroki, 2015, Cancer medicine.

Microbiome profile of the amniotic fluid as a predictive biomarker of perinatal outcome

M. Hattori, S. Miyamoto, Fusanori Yotsumoto, 2017, Scientific Reports.

Clinical Significance of Heparin-Binding Epidermal Growth Factor–Like Growth Factor and A Disintegrin and Metalloprotease 17 Expression in Human Ovarian Cancer

Satoshi O. Suzuki, E. Oki, Y. Maehara, 2005, Clinical Cancer Research.

The modifying effects of green tea polyphenols on acute colitis and inflammation‐associated colon carcinogenesis in male ICR mice

Takuji Tanaka, S. Miyamoto, A. Murakami, 2010, BioFactors.

Suppressive effects of nobiletin on hyperleptinemia and colitis-related colon carcinogenesis in male ICR mice.

Takuji Tanaka, S. Miyamoto, A. Murakami, 2008, Carcinogenesis.

Intestinal lineage commitment of embryonic stem cells.

S. Miyamoto, R. Verma, C. Giardina, 2011, Differentiation; research in biological diversity.

DNA methylation analysis of human myoblasts during in vitro myogenic differentiation: de novo methylation of promoters of muscle-related genes and its involvement in transcriptional down-regulation.

K. Okamura, S. Takada, S. Miyamoto, 2015, Human molecular genetics.

The biological role of the unique molecule RCAS1: a bioactive marker that induces connective tissue remodeling and lymphocyte apoptosis.

S. Miyamoto, N. Wake, M. Nakashima, 2008, Frontiers in bioscience : a journal and virtual library.

Chromosomal deletions and K‐ras gene mutations in human endometrial carcinomas

S. Miyamoto, N. Wake, T. Sasazuki, 1992, International journal of cancer.

Global gene expression analysis of the mouse colonic mucosa treated with azoxymethane and dextran sodium sulfate

Takuji Tanaka, S. Miyamoto, S. Sugie, 2007, BMC Cancer.

Spontaneous regression of quiescent gestational trophoblastic disease after pregnancy: a case report

S. Miyamoto, A. Sekizawa, T. Mimura, 2019, BMC Women's Health.

Role of Notch signaling in colon homeostasis and carcinogenesis

S. Miyamoto, D. Rosenberg, 2011, Cancer science.

Massively parallel sequencing of cell-free DNA in plasma for detecting gynaecological tumour-associated copy number alteration

S. Miyamoto, M. Nakabayashi, A. Sekizawa, 2018, Scientific Reports.

Synergistic anti‐tumor effect of paclitaxel with CRM197, an inhibitor of HB‐EGF, in ovarian cancer

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2009, International journal of cancer.

Usefulness of LigaSureTM in laparoscopic salpingectomy for tubal pregnancy

S. Miyamoto, Fusanori Yotsumoto, Tomohiro Ito, 2022, JAPANESE JOURNAL OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY.

Biologic significance of receptor‐binding cancer antigen expressed on SiSo cells (RCAS1) as a pivotal regulator of tumor growth through angiogenesis in human uterine cancer

S. Miyamoto, E. Mekada, N. Wake, 2007, Cancer.

Transformation to small-cell lung cancer as a mechanism of acquired resistance to crizotinib and alectinib.

S. Miyamoto, S. Ikushima, R. Ono, 2015, Japanese journal of clinical oncology.

Efficacy of ligand-based targeting for the EGF system in cancer.

S. Miyamoto, Fusanori Yotsumoto, S. Horiuchi, 2009, Anticancer research.

Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma

Y. Hosomi, M. Shibuya, S. Miyamoto, 2016, BMC Cancer.

Integrin signal masks growth-promotion activity of HB-EGF in monolayer cell cultures

S. Miyamoto, E. Mekada, H. Mizushima, 2009, Journal of Cell Science.

Clinical significance of cervical length shortening before 31 weeks' gestation assessed by longitudinal observation using transvaginal ultrasonography

S. Miyamoto, T. Yoshizato, T. Kawarabayashi, 2008, The journal of obstetrics and gynaecology research.

Antitumor effects of CRM197, a specific inhibitor of HB-EGF, in T-cell acute lymphoblastic leukemia.

S. Miyamoto, Fusanori Yotsumoto, M. Kuroki, 2011, Anticancer research.

A critical review of “uterine leiomyoma” with subsequent recurrence or metastasis: A multicenter study of 62 cases

S. Miyamoto, K. Ushijima, H. Katabuchi, 2022, The journal of obstetrics and gynaecology research.

Smooth muscle tumor of uncertain malignant potential that occurred after laparoscopic myomectomy: A case report

S. Miyamoto, M. Kushima, A. Sekizawa, 2020, JAPANESE JOURNAL OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY.

Effects of Walnut Consumption on Colon Carcinogenesis and Microbial Community Structure

G. Weinstock, S. Miyamoto, D. Rosenberg, 2016, Cancer Prevention Research.

A novel rasH2 mouse carcinogenesis model that is highly susceptible to 4-NQO-induced tongue and esophageal carcinogenesis is useful for preclinical chemoprevention studies.

Takuji Tanaka, S. Miyamoto, A. Murakami, 2008, Carcinogenesis.

HB‐EGF orchestrates the complex signals involved in triple‐negative and trastuzumab‐resistant breast cancer

E. Tokunaga, E. Oki, Y. Maehara, 2010, International Journal of Cancer.

Within-Host Variations of Human Papillomavirus Reveal APOBEC Signature Mutagenesis in the Viral Genome

S. Miyamoto, Y. Ishii, S. Mori, 2018, Journal of Virology.

FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma

S. Miyamoto, L. Rui, J. Eickhoff, 2016, Oncogene.

Clinical usefulness of contrast-enhanced color Doppler ultrasonography in invasive and noninvasive gestational trophoblastic diseases: a preliminary study.

S. Miyamoto, T. Kawarabayashi, T. Hachisuga, 2011, The Journal of reproductive medicine.

Uterine inversion due to a leiomyoma on postpartum day 41: A case report

S. Miyamoto, H. Tsujioka, K. Shirota, 2011, The journal of obstetrics and gynaecology research.

A case of fetal osteogenesis imperfecta type 2A: longitudinal observation of natural course in utero and pitfalls for prenatal ultrasound diagnosis

S. Miyamoto, T. Yoshizato, Ibuki Kimura, 2015, Journal of Medical Ultrasonics.

Significant Antitumor Activity of Pazopanib in a Patient with PDGFRB-Mutated Metastatic Phyllodes Tumor: a Case Report

S. Miyamoto, S. Ichi, Y. Tabei, 2021, SN Comprehensive Clinical Medicine.

A possible clinical adaptation of CRM197 in combination with conventional chemotherapeutic agents for ovarian cancer.

S. Miyamoto, Fusanori Yotsumoto, M. Kuroki, 2011, Anticancer research.

Targeting the heparin-binding epidermal growth factor-like growth factor in ovarian cancer therapy

S. Miyamoto, Fusanori Yotsumoto, M. Kuroki, 2011, Current opinion in obstetrics & gynecology.

Emerging strategies for ErbB ligand-based targeted therapy for cancer.

S. Miyamoto, Fusanori Yotsumoto, S. Horiuchi, 2010, Anticancer research.

Low-Dose Erlotinib Treatment in Elderly or Frail Patients With EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter Phase 2 Trial.

Y. Hosomi, S. Miyamoto, N. Kikuchi, 2020, JAMA oncology.

Salvage Chemotherapy Following Osimertinib in Non-small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutation

S. Miyamoto, N. Awano, N. Kuse, 2020, AntiCancer Research.

Metronomic doxifluridine chemotherapy combined with the anti‐angiogenic agent TNP‐470 inhibits the growth of human uterine carcinosarcoma xenografts

S. Miyamoto, T. Kawarabayashi, S. Ogata, 2011, Cancer science.

Effect of surgical experience in total laparoscopic cystectomy for mature ovarian cystic teratomas on patient outcomes

S. Miyamoto, T. Hachisuga, H. Tsujioka, 2010 .

Vaginal microbiome as a tool for prediction of chorioamnionitis in preterm labor: a pilot study

M. Hattori, S. Miyamoto, Fusanori Yotsumoto, 2021, Scientific Reports.

Potential for molecularly targeted therapy against epidermal growth factor receptor ligands.

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2009, Anticancer research.

ATP-binding cassette superfamily transporter gene expression in human primary ovarian carcinoma.

N. Kinukawa, S. Miyamoto, Y. Oda, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

ATP-binding Cassette Superfamily Transporter Gene Expression in Human Primary Ovarian Carcinoma 1

N. Kinukawa, S. Miyamoto, Y. Oda, 2002 .

Preoperative Magnetic Resonance Imaging versus Intraoperative Frozen Section Diagnosis for Predicting the Deep Myometrial Invasion in Endometrial Cancer: Our Experience and Literature Review

Y. Ohgiya, S. Miyamoto, M. Kushima, 2021, The journal of obstetrics and gynaecology research.

Dietary flavonoids as cancer-preventive and therapeutic

S. Miyamoto, H. Ashida, A. Murakami, 2011 .

Loss of motility‐related protein 1 (MRP1/CD9) and integrin α3 expression in endometrial cancers

Y. Maehara, S. Miyamoto, E. Mekada, 2001 .

Biological response modifiers used in cancer biotherapy.

S. Miyamoto, Fusanori Yotsumoto, M. Kuroki, 2012, Anticancer research.

Potential for Sesame Seed-Derived Factors to Prevent Colorectal Cancer

S. Miyamoto, M. Mutoh, Masami Komiya, 2016 .

Heparin-Binding EGF-Like Growth Factor Is a Promising Target for Ovarian Cancer Therapy

M. Kai, S. Miyamoto, H. Yagi, 2004, Cancer Research.

The Radical Scavenger NZ-419 Suppresses Intestinal Polyp Development in Apc-Mutant Mice

S. Miyamoto, Masaki Kobayashi, Takumi Narita, 2020, Journal of clinical medicine.

Heparin-binding epidermal growth factor-like growth factor as a new target molecule for cancer therapy.

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2008, Advances in experimental medicine and biology.

Heparin-binding epidermal growth factor–like growth factor promotes transcoelomic metastasis in ovarian cancer through epithelial-mesenchymal transition

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2008, Molecular Cancer Therapeutics.

Clinical significance of amphiregulin and epidermal growth factor in colostrum

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2012, Archives of Gynecology and Obstetrics.

Validation of HB-EGF and amphiregulin as targets for human cancer therapy.

Satoshi O. Suzuki, E. Oki, S. Miyamoto, 2008, Biochemical and biophysical research communications.

MicroRNA‐135a‐3p as a promising biomarker and nucleic acid therapeutic agent for ovarian cancer

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2017, Cancer science.

Clinical significance of cell-free and concentrated ascites re-infusion therapy for advanced and recurrent gynecological cancer.

S. Miyamoto, T. Yoshizato, Yoko Takahashi, 2012, Anticancer research.

Clinicopathologic and familial characteristics of endometrial carcinoma with multiple primary carcinomas in relation to the loss of protein expression of MSH2 and MLH1

S. Miyamoto, T. Saito, H. Baba, 2001, Cancer.

Production of Sry knockout mouse using TALEN via oocyte injection

T. Kikusui, S. Takada, S. Miyamoto, 2013, Scientific Reports.

Inhibition of NF-kappaB transcriptional activity enhances fucoxanthinol-induced apoptosis in colorectal cancer cells

S. Miyamoto, Takumi Narita, T. Yano, 2019, Genes and Environment.

Aqueous and ethanolic extract fractions from the Brazilian propolis suppress azoxymethane-induced aberrant crypt foci in rats.

Takuji Tanaka, S. Miyamoto, Mihye Kim, 2008, Oncology reports.

CT features for diagnosing acute torsion of uterine subserosal leiomyoma

Y. Ohgiya, S. Miyamoto, M. Hirose, 2018, Japanese Journal of Radiology.

Trophic and immunomodulatory effects of adipose tissue derived stem cells in a preclinical murine model of endometriosis

S. Miyamoto, Fusanori Yotsumoto, K. Nabeshima, 2021, Scientific Reports.

A case of cystic biliary atresia with an antenatally detected cyst: the possibility of changing from a correctable type with a cystic lesion (I cyst) to an uncorrectable one (IIId)

S. Miyamoto, T. Yoshizato, K. Nabeshima, 2010, Pediatric Surgery International.

The successful detection of postpartum unruptured vaginal pseudoaneurysm using ultrasonography: a case report

S. Miyamoto, T. Yoshizato, H. Kondo, 2014, SpringerPlus.

Cumulative Summation Analysis of Learning Curve for Robotic-assisted Hysterectomy in Patients With Gynecologic Tumors

S. Miyamoto, Fusanori Yotsumoto, S. Yasunaga, 2022, AntiCancer Research.

Predicting high risk birth from real large-scale cardiotocographic data using multi-input convolutional neural networks

Chihiro Shibata, Alkanan Mohannad, Kohei Miyata, 2021, Nonlinear Theory and Its Applications, IEICE.

Activated EphA2 Processing by MT1-MMP Is Involved in Malignant Transformation of Ovarian Tumours In Vivo

S. Miyamoto, Yoko Takahashi, K. Nabeshima, 2018, AntiCancer Research.

Catalpa seed oil rich in 9t,11t,13c-conjugated linolenic acid suppresses the development of colonic aberrant crypt foci induced by azoxymethane in rats.

Takuji Tanaka, S. Miyamoto, K. Miyashita, 2006, Oncology reports.

Clinical significance of heparin-binding epidermal growth factor-like growth factor in peritoneal fluid of ovarian cancer

S. Miyamoto, H. Yagi, E. Mekada, 2005, British Journal of Cancer.

Increased visceral fat mass and insulin signaling in colitis-related colon carcinogenesis model mice.

Takuji Tanaka, S. Miyamoto, A. Murakami, 2010, Chemico-biological interactions.

Microbiome profile of the amniotic fluid as a predictive biomarker of perinatal outcome

M. Hattori, S. Miyamoto, Fusanori Yotsumoto, 2017, Scientific Reports.

Predictive factors related to the efficacy of pelvic arterial embolization for postpartum hemorrhage: a retrospective analysis of 21 cases.

S. Miyamoto, T. Yoshizato, K. Yoshimitsu, 2014, Taiwanese journal of obstetrics & gynecology.

Dietary flavonoids suppress azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice.

Takuji Tanaka, S. Miyamoto, A. Murakami, 2010, Chemico-biological interactions.

Abstract 4524: Targeting Bcl-2 family proteins in adult T-cell leukemia/lymphoma: in vitro and in vivo effects of a novel Bcl-2 family inhibitor, ABT-737

S. Miyamoto, Fusanori Yotsumoto, M. Kuroki, 2010 .

Dietary β-cryptoxanthin inhibits N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice

Takuji Tanaka, S. Miyamoto, K. Miyazawa, 2007 .

MicroRNAs miR-4535 and miR-1915-5p in amniotic fluid as predictive biomarkers for chorioamnionitis

Tetsuya Hayashi, S. Miyamoto, Fusanori Yotsumoto, 2021, Future science OA.

A lipophilic statin, pitavastatin, suppresses inflammation‐associated mouse colon carcinogenesis

Takuji Tanaka, S. Miyamoto, T. Tsukamoto, 2007, International journal of cancer.

Suppression of intestinal carcinogenesis in Apc-mutant mice by limonin

S. Miyamoto, T. Yano, M. Mutoh, 2015, Journal of clinical biochemistry and nutrition.

Clinical Features of Recurrence in Patients Without Residual Tumour in Endometrial Cancer

S. Miyamoto, Fusanori Yotsumoto, Y. Kanamori, 2019, AntiCancer Research.

Whole-genome analysis of human papillomavirus genotypes 52 and 58 isolated from Japanese women with cervical intraepithelial neoplasia and invasive cervical cancer

S. Miyamoto, Y. Ishii, S. Mori, 2017, Infectious Agents and Cancer.

Therapeutic impact of mutation subtypes and concomitant STK11 mutations in KRAS–mutated non-small cell lung cancer (NSCLC): A result of nationwide genomic screening project (LC-SCRUM-Japan).

S. Miyamoto, S. Matsumoto, K. Yoh, 2020 .

Metronomic irinotecan chemotherapy combined with ultrasound irradiation for a human uterine sarcoma xenograft

K. Tachibana, S. Miyamoto, T. Kawarabayashi, 2011, Cancer science.

Effects of NSAIDs on the risk factors of colorectal cancer: a mini review

S. Miyamoto, K. Wakabayashi, Y. Totsuka, 2016, Genes and Environment.

Erratum to: Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma

Y. Hosomi, M. Shibuya, S. Miyamoto, 2016, BMC Cancer.

Reply to letter to the editor Comment on: Dietary flavonoids suppress azoxymethane-induced colonic preneoplastic lesions in male C57BL/Ksj-db/db mice

Takuji Tanaka, S. Miyamoto, A. Murakami, 2010 .

Diet supplemented with citrus unshiu segment membrane suppresses chemically induced colonic preneoplastic lesions and fatty liver in male db/db mice

Takuji Tanaka, S. Miyamoto, Y. Hirose, 2007, International journal of cancer.

Regulatory mechanisms of the HB-EGF autocrine loop in inflammation, homeostasis, development and cancer.

S. Miyamoto, Fusanori Yotsumoto, M. Kuroki, 2012, Anticancer research.

Nuclear Factor Kappa B (NF-κB) in Inflammation

S. Miyamoto, Fusanori Yotsumoto, M. Kuroki, 2012 .

BK-UM in patients with recurrent ovarian cancer or peritoneal cancer: a first-in-human phase-I study

S. Miyamoto, Fusanori Yotsumoto, T. Yoshizato, 2017, BMC Cancer.

Contribution of transcription factor, SP1, to the promotion of HB-EGF expression in defense mechanism against the treatment of irinotecan in ovarian clear cell carcinoma

S. Takada, S. Miyamoto, Fusanori Yotsumoto, 2014, Cancer medicine.

Molecular Hierarchy of Heparin-Binding EGF-like Growth Factor–Regulated Angiogenesis in Triple-Negative Breast Cancer

E. Tokunaga, E. Oki, Y. Maehara, 2013, Molecular Cancer Research.

A Novel Anti-Human HB-EGF Monoclonal Antibody with Multiple Antitumor Mechanisms against Ovarian Cancer Cells

K. Shitara, S. Miyamoto, H. Yagi, 2011, Clinical Cancer Research.

Amphiregulin regulates the activation of ERK and Akt through epidermal growth factor receptor and HER3 signals involved in the progression of pancreatic cancer

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2010, Cancer science.

Anticorps monoclonal capable de se lier à un facteur de croissance de type hb-egf (heparin-binding epidermal growth factor)

K. Shitara, S. Miyamoto, E. Mekada, 2008 .

Inhibition of Phosphodiesterase-4 (PDE4) activity triggers luminal apoptosis and AKT dephosphorylation in a 3-D colonic-crypt model

S. Miyamoto, M. Kuroki, D. Tyson, 2012, Molecular Cancer.

KRAS up-regulates the expression of miR-181a, miR-200c and miR-210 in a three-dimensional-specific manner in DLD-1 colorectal cancer cells.

S. Miyamoto, M. Kuroki, S. Shirasawa, 2012, Anticancer research.

1 KRAS Upregulates miR-181 a , miR-200 c and miR-210 in a Three-Dimensional-Specific Manner in DLD-1 Colorectal Cancer Cells

S. Miyamoto, M. Kuroki, S. Shirasawa, 2015 .

Publisher Correction: Massively parallel sequencing of cell-free DNA in plasma for detecting gynaecological tumour-associated copy number alteration

S. Miyamoto, M. Nakabayashi, A. Sekizawa, 2018, Scientific Reports.

Amphiregulin is a prognostic factor in colorectal cancer.

K. Shirouzu, S. Miyamoto, Y. Akagi, 2012, Anticancer research.

Inhibition of NF-kappaB transcriptional activity enhances fucoxanthinol-induced apoptosis in colorectal cancer cells

S. Miyamoto, Takumi Narita, T. Yano, 2019, Genes and Environment.

The relationship between torsion and of the length of the peduncle in patients with uterine subserosal leiomyoma

Y. Ohgiya, S. Miyamoto, A. Sekizawa, 2016 .

The combination of maternal blood and amniotic fluid biomarkers improves the predictive accuracy of histologic chorioamnionitis.

S. Miyamoto, Fusanori Yotsumoto, H. Arima, 2019, Placenta.

Association of Serum HB-EGF Value and Response to Chemotherapy in Patients with Recurrent Ovarian Cancer

S. Miyamoto, Fusanori Yotsumoto, M. Kuroki, 2018, AntiCancer Research.

Citrus Auraptene Suppresses Azoxymethane-Induced Colonic Preneoplastic Lesions in C57BL/KsJ-db/db Mice

Takuji Tanaka, S. Miyamoto, Kei Hayashi, 2007, Nutrition and cancer.

Clinical development of molecular-targeted therapies for non-small cell lung cancer through nationwide genome screening in Japan (LC-SCRUM-Japan)

Y. Ohe, S. Miyamoto, K. Yoh, 2019, Annals of Oncology.

Diphtheria toxin mutant CRM197 possesses weak EF2-ADP-ribosyl activity that potentiates its anti-tumorigenic activity.

S. Miyamoto, E. Mekada, M. Ohishi, 2007, Journal of biochemistry.

Proteolytic activation of heparin‐binding EGF‐like growth factor by membrane‐type matrix metalloproteinase‐1 in ovarian carcinoma cells

S. Miyamoto, Fusanori Yotsumoto, E. Mekada, 2011, Cancer science.

Efficacy and safety of stereotactic body radiotherapy using CyberKnife in Stage I primary lung tumor

Shingo Miyamoto, Takehiro Izumo, S. Miyamoto, 2017, Japanese journal of clinical oncology.

Repeated biopsy results.

S. Miyamoto, 2016, Japanese journal of clinical oncology.

Rabdosianone I, a Bitter Diterpene from an Oriental Herb, Suppresses Thymidylate Synthase Expression by Directly Binding to ANT2 and PHB2

T. Sakai, S. Miyamoto, T. Kameda, 2021, Cancers.

Novel screening system revealed that intracellular cholesterol trafficking can be a good target for colon cancer prevention

S. Miyamoto, Takumi Narita, M. Mutoh, 2019, Scientific Reports.

Feasibility study of first-line chemotherapy using Pemetrexed and Bevacizumab for advanced or recurrent nonsquamous non-small cell lung cancer in elderly patients: TORG1015

Masahiro Yoshida, S. Miyamoto, S. Ikeda, 2016, BMC Cancer.

Medical costs of lung cancer care in Japan during the first one or two years after initial diagnosis.

S. Miyamoto, H. Kunitoh, A. Igarashi, 2021, Japanese journal of clinical oncology.

Erratum to: Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma

Y. Hosomi, M. Shibuya, S. Miyamoto, 2016, BMC Cancer.

Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma

Y. Hosomi, M. Shibuya, S. Miyamoto, 2015, BMC Cancer.

HB-EGF involved in peritoneal implantation of ovarian cancer

S. Miyamoto, H. Yagi, Fusanori Yotsumoto, 2006 .

Novel screening system revealed that intracellular cholesterol trafficking can be a good target for colon cancer prevention

S. Miyamoto, Takumi Narita, M. Mutoh, 2019, Scientific Reports.

A specific inducible nitric oxide synthase inhibitor, ONO-1714 attenuates inflammation-related large bowel carcinogenesis in male Apc(Min/+) mice.

Takuji Tanaka, S. Miyamoto, K. Wakabayashi, 2007, International journal of cancer.

Whole-genome analysis of human papillomavirus genotypes 52 and 58 isolated from Japanese women with cervical intraepithelial neoplasia and invasive cervical cancer

S. Miyamoto, Y. Ishii, S. Mori, 2017, Infectious Agents and Cancer.

Safety and Anti-tumor Effects of Docetaxel Plus Cisplatin in Intermediate- and High-risk Endometrial Cancer.

S. Miyamoto, Fusanori Yotsumoto, Yoko Takahashi, 2016, Anticancer research.

Dietary flavonoids suppress azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice.

Takuji Tanaka, S. Miyamoto, A. Murakami, 2010, Chemico-biological interactions.

[Two cases of stomach primary diffuse large B cell lymphoma remitted by Helicobacter pylori eradication therapy].

S. Miyamoto, T. Hishima, R. Okamoto, 2008, Gan to kagaku ryoho. Cancer & chemotherapy.

Platinum hypersensitivity and desensitization.

S. Miyamoto, Rika Okada, Kazumichi Ando, 2015, Japanese journal of clinical oncology.

Metronomic doxifluridine chemotherapy combined with the anti‐angiogenic agent TNP‐470 inhibits the growth of human uterine carcinosarcoma xenografts

S. Miyamoto, T. Kawarabayashi, S. Ogata, 2011, Cancer science.

16 (1988) 133 Intrauterine treatment of idiopathic hydrops fetalis

S. Miyamoto, H. Maeda, K. Hara, 1988 .

HB‐EGF orchestrates the complex signals involved in triple‐negative and trastuzumab‐resistant breast cancer

E. Tokunaga, E. Oki, Y. Maehara, 2010, International journal of cancer.

Amphiregulin is much more abundantly expressed than transforming growth factor-alpha and epidermal growth factor in human follicular fluid obtained from patients undergoing in vitro fertilization-embryo transfer.

S. Miyamoto, Fusanori Yotsumoto, T. Kawarabayashi, 2009, Fertility and sterility.

The association between p16 and Ki‐67 immunohistostaining and the progression of cervical intraepithelial neoplasia grade 2

S. Miyamoto, M. Kushima, J. Hasegawa, 2016, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Rapid Progression of Nulliparous Labor Increases the Risk of Preterm Delivery in a Subsequent Pregnancy

S. Miyamoto, T. Yoshizato, Y. Miyake, 2014 .